SAN DIEGO (AP) — SAN DIEGO (AP) — Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $9.9 million in its third quarter.

The San Diego-based company said it had a loss of 17 cents per share.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The biopharmaceutical company posted revenue of $179,000 in the period, which matched Street forecasts.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News